biotech · SARS-CoV-2 Infection · Breast Cancer
Henlius USA
Shanghai Henlius Biotech
Henlius USA patent portfolio — 0 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Milpitas, USA HQ
2010 Founded
45 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- Milpitas, USA
- Founded
- 2010
- Employees
- 45
- Programs
- 3
- Drugs
- 4
- Patents
- 0
Henlius USA patents
0 pharmaceutical patents indexed for Henlius USA. 0 expire within 24 months.
Henlius USA has 0 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
No patents matched
Frequently asked questions
How many patents does Henlius USA have?
0 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Henlius USA patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.